Inactive Instrument
CTT Pharmaceutical Holdings, Inc. Stock Other OTC
Stocks
CTTH
US12651E1064
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 3.88M 3.4M 3.17M 2.9M 5.46M 373M 5.54M 37.58M 14.68M 183M 14.55M 14.23M 634M | P/E 2024 |
-11.9x | P/E 2025 | -22.2x |
|---|---|---|---|---|---|
| Enterprise Value | 3.88M 3.41M 3.17M 2.91M 5.46M 374M 5.55M 37.62M 14.7M 184M 14.56M 14.25M 635M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
50.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -22.52% |
| Manager | Title | Age | Since |
|---|---|---|---|
Ryan Khouri
CEO | Chief Executive Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Allen Greenspoon
BRD | Director/Board Member | 71 | 2014-09-08 |
Ryan Khouri
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -22.52% | -0.09% | - | - | 3.88M | ||
| +1.07% | -3.49% | -3.25% | +12.87% | 46.86B | ||
| +0.25% | +1.65% | +408.41% | +629.49% | 40.23B | ||
| -0.27% | +4.45% | +9.93% | +66.92% | 36.23B | ||
| +0.35% | +0.87% | +3.60% | -8.81% | 34.72B | ||
| +3.14% | +1.02% | +3.37% | +38.15% | 27.89B | ||
| -0.73% | +11.84% | +31.97% | +143.53% | 16.79B | ||
| +0.47% | -2.74% | - | - | 16.74B | ||
| +0.42% | -5.52% | +0.76% | +8.50% | 13.12B | ||
| -2.68% | -2.49% | -15.00% | -31.68% | 12.7B | ||
| Average | -2.05% | +0.83% | +54.97% | +107.37% | 27.25B | |
| Weighted average by Cap. | +0.48% | +0.91% | +75.32% | +136.64% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -250K -220K -204K -188K -352K -24.1M -358K -2.43M -948K -11.85M -939K -919K -40.96M | -156K -137K -127K -117K -220K -15.01M -223K -1.51M -591K -7.38M -585K -573K -25.52M |
| Net Debt | 16.82K 14.77K 13.74K 12.61K 23.69K 1.62M 24.05K 163K 63.73K 796K 63.14K 61.78K 2.75M | 3.46K 3.03K 2.82K 2.59K 4.87K 333K 4.94K 33.51K 13.09K 164K 12.97K 12.69K 566K |
Employees
-
















